Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigao Huang

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancers|August 26, 2022
Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched AnalysisWei Zhou, Pang Wang, Xinyu Ti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 6, 2023
Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironmentShigao Huang, Fuqiang Xing, Yeneng Dai, et al.
International Immunopharmacology|April 3, 2012
Protective effects of a novel trimerized sTNFRII on acute liver injuryMansheng Luo, Dan Liu, Lingmin Zhang, et al.
Computational and Structural Biotechnology Journal|June 30, 2021
Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurementsKai Zhou, Yaoting Sun, Lu Li, et al.
Theranostics|October 14, 2021
Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platformFuqiang Xing, Yu-Cheng Liu, Shigao Huang, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancers|August 26, 2022
Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched AnalysisWei Zhou, Pang Wang, Xinyu Ti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 6, 2023
Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironmentShigao Huang, Fuqiang Xing, Yeneng Dai, et al.
International Immunopharmacology|April 3, 2012
Protective effects of a novel trimerized sTNFRII on acute liver injuryMansheng Luo, Dan Liu, Lingmin Zhang, et al.
Computational and Structural Biotechnology Journal|June 30, 2021
Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurementsKai Zhou, Yaoting Sun, Lu Li, et al.
Theranostics|October 14, 2021
Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platformFuqiang Xing, Yu-Cheng Liu, Shigao Huang, et al.
Pageof 5